Healthcare & Life Sciences
Cellectar Biosciences, Inc.
United Stateswww.cellectar.com/
Cellectar Biosciences, Inc. is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About Cellectar Biosciences, Inc.
Cellectar Biosciences, Inc. is a company headquartered in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Cellectar Biosciences develops targeted cancer therapies using its Phospholipid Drug Conjugate (PDC) platform to deliver therapeutic agents, including radioisotopes and cytotoxins, directly to tumor cells to maximize efficacy and minimize off-target effects.
Explore Cellectar Biosciences, Inc.'s full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.